This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dietz, J. R. Articles by Echtenkamp, S. F. Search for Related Content PubMed PubMed Citation Articles by Dietz, J. R. Articles by Echtenkamp, S. F.

Hypertension, Vol 5, 482-488, Copyright © 1983 by American Heart Association

ARTICLES

Effects of intrarenal infusion of calcium entry blockers in anesthetized dogs

JR Dietz, JO Davis, RH Freeman, D Villarreal and SF Echtenkamp

Renal function and renin release were studied in anesthetized, uninephrectomized dogs during intrarenal infusions of the calcium influx blockers, verapamil and nifedipine. Verapamil increased renal blood flow by 20% (p less than 0.05) but did not alter glomerular filtration rate. Verapamil produced five-to-seven fold increases in urine flow and the rates of excretion of sodium and chloride (p less than 0.01). Significant increases in the rates of excretion of potassium, calcium and magnesium were also observed. Despite its striking effects on renal function, verapamil, in nonhypotensive doses, failed to alter renin secretion. Intrarenal infusion of nifedipine had no consistent effect on renal blood flow or the rate of glomerular filtration but increased urine flow and the rates of excretion of sodium and chloride by more than three fold (p less than 0.01). Nonhypotensive doses of nifedipine had no significant effect on renin release. In dogs with a denervated nonfiltering kidney, an intrarenal verapamil or nifedipine infusion did not produce a significant change in renin release. This study demonstrates a striking effect of calcium entry blockers on the reabsorption of sodium, chloride, and water by the renal tubules in intact dogs but renin release did not increase unless hypotension occurred.

This article has been cited by other articles:

				K. Hayashi, S. Wakino, N. Sugano, Y. Ozawa, K. Homma, and T. Saruta Ca2+ Channel Subtypes and Pharmacology in the Kidney Circ. Res., February 16, 2007; 100(3): 342 - 353. [Abstract] [Full Text] [PDF]

				A. S. Segal, J. P. Hayslett, and G. V. Desir On the natriuretic effect of verapamil: inhibition of ENaC and transepithelial sodium transport Am J Physiol Renal Physiol, October 1, 2002; 283(4): F765 - F770. [Abstract] [Full Text] [PDF]

				T. Yamasaki, M. Ohmagari, I. Tamai, K. Hayashi, and Y. Matsumura Inhibitory Effects of AE0047, a New Dihydropyridine Ca2+ Channel Blocker, on Renal Nerve Stimulation-Induced Renal Actions in Anesthetized Dogs J. Pharmacol. Exp. Ther., June 1, 2000; 293(3): 1040 - 1047. [Abstract] [Full Text]

				M. Epstein Calcium Antagonists and Renal Protection: Current Status and Future Perspectives Arch Intern Med, August 1, 1992; 152(8): 1573 - 1584. [Abstract] [PDF]

				Drugs Five Years Later: Nifedipine in Myocardial Ischemia, Systemic Hypertension, and Other Cardiovascular Disorders Ann Intern Med, November 1, 1986; 105(5): 714 - 729. [Abstract] [PDF]